The FDA warns patients about counterfeit Ozempic that may be in circulation

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about “several hundred units” of the drug that made it onto the market outside the company’s approved supply chain.

(Image credit: David J. Phillip)

Share on Facebook

Tweet

Follow us